Skip to main content

Table 1 Clinical information of patients with head and neck squamous cell carcinoma.

From: Functional microarray analysis suggests repressed cell-cell signaling and cell survival-related modules inhibit progression of head and neck squamous cell carcinoma

 

pN+

pN0

Recurrent*

Non-recurrent*

Samples

61

20

20

27

Oral cavity (%, n)

55.7 (34)

65.0 (13)

50.0 (10)

44.4 (12)

Oropharynx (%, n)

44.3 (27)

35.0 (7)

35.0 (7)

40.7 (11)

Hypopharynx (%, n)

0

0

5.0 (1)

7.4 (2)

Larynx (%, n)

0

0

10.0 (2)

7.4 (2)

Age (mean in years**)

56.9 (23-85)

61.2 (35-88)

57.2 (39-74)

55.5 (23-78)

Male gender (%, n)

82.0 (50)

80.0 (16)

90.0 (18)

74.1 (20)

Smoking (%, n)

83.6 (51)

70.0 (14)

95.0 (19)

74.1 (20)

Alcohol (%, n)

67.2 (41)

50.0 (10)

80.0 (16)

63.0 (17)

pT3-4 (%, n)

73.8 (45)

50.0 (10)

80.0 (16)

59.3 (16)

Follow-up (years**)

0 - 9.03

0,01 - 7,80

0.37 - 3.47

2.41 - 9.03

Locoregional recurrence or

44.3 (27)

25.0 (5)

  

distant metastasis (%, n)

    
  1. Note: *All patients were submitted to surgery and neck dissection, presented pathologic positive lymph node status, and were treated with adjuvant radiotherapy. Recurrence was considered as locoregional and/or distant metastasis after treatment (biopsy proven or by imaging). **minimum - maximum